NCT04086797View on ClinicalTrials.gov

DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese Subjects

NACompletedINTERVENTIONAL

Enrollment

178

Participants

Timeline

Start Date

September 11, 2019

Primary Completion Date

April 8, 2021

Study Completion Date

April 8, 2021

Conditions

OverweightObesity

Interventions

DIETARY_SUPPLEMENT

IQP-AE-103

1980 mg

DIETARY_SUPPLEMENT

Placebo

Placebo

Trial Locations (1)

13467

analyze & realize GmbH, Berlin

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Analyze & Realize

NETWORK

lead

Perrigo CSCI

INDUSTRY

NCT04086797 - DBRPC Study to Evaluate the Efficacy and Safety of IQP-AE-103 in Overweight and Moderately Obese Subjects | Biotech Hunter | Biotech Hunter